))
Redefining Vision: A Pioneer’s Quest to Combat Myopia in Children
Manage episode 396378826 series 3501626
Content provided by Midwest Momentum. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Midwest Momentum or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Host Michelle Gatchell shared how having Myopia cause major struggles in keeping up with lessons as a child. - a sentiment echoed by Myoptechs' CEO, Paul Grimm our guest on Midwest Momentum. Together, we traverse the exciting landscape of Ohio's biotech innovations, particularly Myoptechs' pioneering soft contact lens technology. Designed to do more than correct vision, these lenses are a promising venture in the fight against the progression of myopia in children, potentially preventing severe eye conditions down the line.
Hear Myoptechs' journey from the germination of a game-changing idea to the intricate dance of securing funding and partnerships. Paul Grimm shares insights into the significant role of The Ohio State University's technology, and the expertise of Dr. Tom Raasch in shaping Myoptechs. This episode discusses initial funding avenues—grants included—to the strategic alliances and brand building essential for navigating the complexities of the medical device industry.
Wrapping up, we spotlight the importance of early detection and intervention in myopia management, especially in the critical developmental window of young children. Tune in and behold the clarity with which Myoptechs is helping children to see not just the world before them, but a future bright with potential.
Chapters
1. Midwest Momentum (00:00:00)
2. Myopia Treatment and Biotech Business Funding (00:05:21)
3. Slowing Myopia Progression Through Clinical Trials (00:17:27)
4. Finding Myoptex and Discussing Biopia Journey (00:28:57)
97 episodes
Share
